Wendy Lane
Endocrinology, Diabetes & Metabolism · Asheville, NCNPI 1073644175
Payments from drug & device makers
Across 1,386 payments — averaging $1338.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1.1M
- Novo Nordisk AS$268K
- Dexcom, Inc.$173K
- Insulet Corporation$170K
- AbbVie$73K
- Lexicon Pharmaceuticals, Inc.$36K
- plus $82K from 42 others
Across 3 payments — averaging $726.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Lexicon Pharmaceuticals, Inc.$2K
What the payments were for
- Consulting fees$78,99716%
- Speaking & faculty fees$292,05960%
- Travel & lodging$99,86520%
- Food & beverage$16,2093%
- Education$1750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$136,958
- RYBELSUS$67,743
- DEXCOM G7 GSS (161)$41,422
- Victoza$37,473
- Tresiba$30,631
- DEXCOM G6 TRANSMITTER$15,968
- GVOKE PFS$14,404
- DEXCOM STELO GLUCOSE BIOSENSOR$10,617
- DEXCOM CGM$8,678
- Omnipod$7,062
- DEXCOM G6 CGM SYSTEM$6,358
- ZEGALOGUE$1,600
- t-slim insulin pump$1,000
- TWIIST$420
- t:slim X2 insulin pump$250
- MINIMED 780G$146
How this compares
$1,855,585 in reported general payments places this provider in the 95th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.
See all endocrinology, diabetes & metabolism providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $91,404 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 71 | $87,111 |
| Tresiba Flextouch U-200Insulin Degludec | 41 | $61,409 |
| FarxigaDapagliflozin Propanediol | 36 | $42,626 |
| MounjaroTirzepatide | 29 | $35,817 |
| JardianceEmpagliflozin | 21 | $33,573 |
| Tresiba Flextouch U-100Insulin Degludec | 49 | $32,465 |
| TrulicityDulaglutide | 14 | $18,367 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $13,262 |
| HumalogInsulin Lispro | 29 | $10,226 |
| Novolog FlexpenInsulin Aspart | 25 | $7,549 |
| Humalog Kwikpen U-100Insulin Lispro | 11 | $3,930 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 21 | $3,131 |
| SynthroidLevothyroxine Sodium | 26 | $1,613 |
| Levothyroxine Sodium | 89 | $897 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,054,367 | $91,40457 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $791 | $64,41072 claims |
| AstraZenecaFarxiga | $31,341 | $42,62636 claims |
| Boehringer IngelheimJardiance | $147 | $33,57321 claims |
| AbbVieSynthroid | $72,859 | $1,61326 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $89789 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 232 endocrinology, diabetes & metabolism providers in North Carolina.
Other endocrinology, diabetes & metabolism in Asheville
- Richard DoddAsheville$526K
- Victor MarlarAsheville$483K
- Lauren BernsteinAsheville$354K
- Michael WilliamsAsheville$25K
- Stephen WeinribAsheville$11K
- Kathryn LucasMorehead City$37.9M
- Mark WarrenGreenville$5M
- Mary LawrenceMorehead City$4.9M
- John ParkerWilmington$4.1M
- John BuseChapel Hill$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.